JUL 1, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Verapamil Hydrochloride (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for verapamil hydrochloride labeling; this is a regulatory action record without clinical trial data and does not establish efficacy or comparative benefit.
Reported
Approval date2026-07-01
Application numberANDA078306
Dosage strengths approved100 mg, 200 mg, 300 mg extended-release cap…